Much of the increase in cancer incidence is explained by the increasing number of elderly in the population.
Even at a relatively advanced age, many have a life expectancy in the range of, or longer than, the expected 5-or 10-year survival of the malignant disease diagnosed.
There are some specific problems related to treatment with chemotherapy in this age group.
There is a decline in organ function, especially renal and cardiac, as well as other limitations in relation to vision, hearing and mobility.
This means that we have to adopt a different attitude both to indications for chemotherapy and to what agents to use.
Social and socioeconomic factors also have to be taken into consideration.
Mots-clés Pascal : Chimiothérapie, Vieillard, Homme, Tumeur maligne, Courbe survie, Critère âge, Toxicité, Anticancéreux, Indication, Impact socioéconomique
Mots-clés Pascal anglais : Chemotherapy, Elderly, Human, Malignant tumor, Survival curve, Age criterion, Toxicity, Antineoplastic agent, Indication, Socioeconomical impact
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0493113
Code Inist : 002B02R02. Création : 19/02/1999.